Determination of β-catenin Expression in Breast Cancer and Its Relationship with Clinicopathologic Parameters.

Background: Abnormal activation of the β-catenin signaling pathway is involved in various malignancies, including breast carcinoma.Aberrant expression of β-catenin has been associated with more aggressive behaviors of breast cancer in some previous studies. .